Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis

Authors

Benjamin A. Olenchock (ORCID: https://orcid.org/0000-0002-8956-5117)
Nune Makarova (ORCID: https://orcid.org/0009-0009-0961-6702)
Prajakta Badri (ORCID: https://orcid.org/0000-0003-1248-616X)
John M. Gansner (ORCID: https://orcid.org/0000-0002-4030-3044)
Farshad Kajbaf
Arun Jayant Sanyal (ORCID: https://orcid.org/0000-0001-8682-5748)
Jörg Täubel (ORCID: https://orcid.org/0000-0002-0010-207X)
Sarah Bond
Weizhi Zhao
Swati Duggal

Institutions

Alnylam Pharmaceuticals (United States) (US)
Virginia Commonwealth University (US)
Regeneron (United States) (US)

Publication Details

Journal: Journal of Hepatology
Published: 2025-06-27
DOI: https://doi.org/10.1016/j.jhep.2025.05.031
Citations: 8
Primary Topic: Liver Disease Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 10.83

Funders

Alnylam Pharmaceuticals
Regeneron Pharmaceuticals

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis

Benjamin A. Olenchock, Nune Makarova, Prajakta Badri, John M. Gansner et al.

Jun 27, 2025

8 citations

Journal of Hepatology

Liver Disease Diagnosis and Treatment

10.83

article

Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis

Benjamin A. Olenchock, Nune Makarova, Prajakta Badri, John M. Gansner, Farshad Kajbaf, Arun Jayant Sanyal, Jörg Täubel, Sarah Bond, Weizhi Zhao, Swati Duggal

June 27, 2025article en

8 citations

Abstract

No abstract available for this paper.

Journal of HepatologyVol. 83(4)

Alnylam Pharmaceuticals (United States) (US), Virginia Commonwealth University (US), Regeneron (United States) (US)

Alnylam Pharmaceuticals, Regeneron Pharmaceuticals

Openalex Percentile: Top 1%

Liver Disease Diagnosis and Treatment

10.83

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.